Literature DB >> 26747439

Endomyocardial fibrosis: missing tricuspid valve and Fontan-like circulation.

Yasuyuki Shiraishi1, Takashi Kohno2, Yoko Fujii-Nishimura3, Masayuki Shimoda3, Yoshihiko Ikeda4, Kazuaki Nakajima1, Takahiko Nishiyama1, Nobuhiro Nishiyama1, Mitsushige Murata1, Yuichiro Maekawa1, Motoaki Sano1, Keiichi Fukuda1.   

Abstract

Endomyocardial fibrosis (EMF) is a progressive type of obliterative/restrictive cardiomyopathy characterized by fibrosis of the apical endomyocardium of the ventricles. Although the prognosis of EMF patients is poor in tropical regions, the exact clinical course and pathogenesis of patients with EMF are not known. Here, we report the rare case with EMF in the seventh decade, who showed the disappearance of papillary muscles, chordae tendineae, and part of the tricuspid valves due to massive right ventricular thrombus. Because of those unusual findings of the isolated RV involvement, we observed continuous forward pulmonary artery flow, as occurring in a Fontan circulation.

Entities:  

Keywords:  Endomyocardial fibrosis; Inflammation; Prognosis; Right ventricle thrombus

Mesh:

Year:  2016        PMID: 26747439     DOI: 10.1007/s00380-015-0792-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  12 in total

1.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

2.  Familial cases of endomyocardial fibrosis in Uganda.

Authors:  A K Patel; J L Ziegler; P G D'Arbela; K Somers
Journal:  Br Med J       Date:  1971-11-06

3.  Right atrial-right ventricular anastomosis for correction of tricuspid atresia.

Authors:  V O Björk; C L Olin; B B Bjarke; C A Thorén
Journal:  J Thorac Cardiovasc Surg       Date:  1979-03       Impact factor: 5.209

4.  Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients.

Authors:  Vera M C Salemi; Carlos E Rochitte; Afonso A Shiozaki; Joalbo M Andrade; José R Parga; Luiz F de Ávila; Luiz A Benvenuti; Ismar N Cestari; Michael H Picard; Raymond J Kim; Charles Mady
Journal:  Circ Cardiovasc Imaging       Date:  2011-03-17       Impact factor: 7.792

5.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

Review 6.  Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease.

Authors:  Ana Olga Mocumbi; Sophie Yacoub; Magdi H Yacoub
Journal:  Heart       Date:  2008-03       Impact factor: 5.994

Review 7.  Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa.

Authors:  Ana Olga H Mocumbi; Ayodele O Falase
Journal:  Heart       Date:  2013-05-16       Impact factor: 5.994

8.  A population study of endomyocardial fibrosis in a rural area of Mozambique.

Authors:  Ana Olga Mocumbi; Maria Beatriz Ferreira; Daniel Sidi; Magdi H Yacoub
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245

9.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study.

Authors:  Andrea Frustaci; Matteo A Russo; Cristina Chimenti
Journal:  Eur Heart J       Date:  2009-06-25       Impact factor: 29.983

10.  Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India.

Authors:  Sandeep Seth; Deepak Thatai; Sanjeev Sharma; Prem Chopra; K K Talwar
Journal:  Eur J Heart Fail       Date:  2004-10       Impact factor: 15.534

View more
  1 in total

1.  Acquired Fontan paradox in isolated right ventricular cardiomyopathy.

Authors:  Mahim Saran; Sivasankaran Sivasubramonian; Sreevilasam P Abhilash; Jaganmohan A Tharakan
Journal:  Ann Pediatr Cardiol       Date:  2016 Sep-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.